Krabeva 400mg Bevacizumab Injection

Krabeva 400mg Bevacizumab Injection is a prescription anti-cancer medication used in the treatment of various cancers, including colorectal cancer, non-small cell lung cancer, kidney cancer, ovarian cancer, and cervical cancer. It contains Bevacizumab, a targeted monoclonal antibody that works by blocking vascular endothelial growth factor (VEGF), a protein responsible for the formation of new blood vessels that support tumor growth. By reducing the blood supply to cancer cells, Krabeva 400mg Bevacizumab Injection helps slow the growth and spread of tumors. Administered as an intravenous infusion under the supervision of an oncology specialist, it is often used in combination with chemotherapy or other cancer therapies to improve treatment outcomes. Regular monitoring during treatment is essential to evaluate effectiveness and manage potential side effects. Patients should use Krabeva 400mg Injection only under the guidance of their healthcare provider.